AOST LTD
Opportunity 70/100 (strong), bankability 65/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: low (52/100)Sparse data coverage. Treat AI-generated outputs as preliminary. Manual diligence essential.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
Corporate timeline (3 events)Click to expand
- 2025-01-23🏢Company incorporatedAs AOST LTD
- 2025-01-23➕VIORA, Alessandro appointeddirector
- 2025-01-23📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Young company: Only 1.2 years old — management layer unlikely to be developed.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Alessandro Viora Individual · British · DOB 08/1987 · age 39 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 23/01/2025 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · G postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AM NURSERY GROUP LIMITED→ SC768675 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AMD MAPLE LIMITED→ SC797976 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| AMIRS HEALTHCARE LIMITED→ SC633331 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ANDREW BIANKIN LTD→ SC500006 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| ANGELA HECHT THERAPY LTD→ SC714674 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ANNE MORRISON HEALTH LTD→ SC854383 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ANNE PENMAN THERAPY LTD.→ SC198398 · est 1999 · no financials extracted | — | — | — | — | 26y | — | — |
| APPLECROSS INVESTMENTS LIMITED→ SC823800 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| APPLECROSS NURSING HOME LIMITED→ SC177933 · est 1997 · no financials extracted | — | — | — | — | 28y | — | — |
| APRICITY LTD→ SC843845 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| AR CURAM (SCOTLAND) LIMITED→ SC776758 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| AR DENTAL LIMITED→ SC400032 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.